Alzheimer’s reshapes the brain

Alzheimer; News from the web:

And thanks to a new imaging system we can see now exactly how.

Researchers at Yale University have led development in to a new type of brain scan designed to detect changes in synapses associated with common brain disorders. Until now, researchers have only be able to detect these changes during autopsies, but by combining a Positron Emission Tomography (PET) scan with a new type of injectable tracer, Yale radiology and biomedical imagining professor Richard Carson was able to measure the synaptic density in a living brain.

Read all about it HERE

New research on plaque build up with Alzheimer’s

Alzheimer; News from the web:

Cambridge researchers have identified — and shown that it may be possible to control — the mechanism that leads to the rapid build-up of the disease-causing ‘plaques’ that are characteristic of Alzheimer’s disease.

Read all about it HERE

New study promises a vaccine is now close to fight Alzheimer’s

Alzheimer; News from the web:

Vaccine for Alzheimer’s disease could be trialed in humans within the next 3-5 years, after researchers from the United States and Australia have uncovered a formulation that they say successfully targets brain proteins that play a role in development and progression of the disease.

Read all about it HERE

Look in the eyes to find Alzheimer’s

Alzheimer; News from the web:

Could it be possible to detect Alzheimer’s disease in the early stages with just an eye exam? That’s the possibility researchers are floating after they were able to spot signs of Alzheimer’s in the retinas of mice using a special, non-invasive camera.

Read all about it HERE

EU funded project brings new perspectives on Alzheimer’s

Alzheimer; News from the web:

An EU project has made important advances in our understanding of how catalytic molecules can treat Alzheimer’s – and other – chronic diseases.

Alzheimer’s disease is the most common form of dementia, with symptoms that include gradually worsening memory loss and confusion. At present there is no cure. Scientists are nonetheless confident that as we learn more about the natural processes of the body, quicker diagnoses and more effective therapies can be developed.

Indeed, the success of the EU-funded ORGANOZYMES project illustrates why medical researchers have cause for optimism. Through bringing in Spanish post-doc researcher Carlos Aydillo on a Marie Curie Intra-European Fellowship, Professor Morten Meldal, Head of the Center of Evolutionary Chemical Biology at the University of Copenhagen, has been able to make significant advances in the field of catalytic molecules.

Read all about it HERE